Alnylam Pharmaceuticals
E100609
UNEXPLORED
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
Referenced by (1)
| Subject (surface form when different) | Predicate |
|---|---|
|
Phillip A. Sharp
→
|
coFounded |